Medicare Enrolled
Dr. Parth Khade, MD
Internal Medicine · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khade from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khade? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khade
Dr. Parth Khade is an internal medicine in Plano, TX, with 11 years in practice. Based on federal Medicare data, Dr. Khade performed 50,204 Medicare services across 2,200 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khade received a total of $19,089 from 45 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khade is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice▲ Top 1% volume in TX$ $19,089 industry payments
Medicare Practice Summary
Medicare Utilization ↗50,204
Medicare services
Top 1% in TX for internal medicine
2,200
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,564 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 17,100 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 8,195 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 4,785 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 4,400 | $43 | $137 |
| Paclitaxel chemotherapy injection | 2,828 | $0 | $8 |
| Immune globulin infusion (Octagam) | 2,050 | $34 | $236 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,200 | $22 | $181 |
| Dexamethasone injection (steroid) | 1,145 | $0 | $1 |
| Injection, bortezomib, 0.1 mg | 1,112 | $4 | $116 |
| Denosumab injection (Prolia/Xgeva) | 840 | $18 | $66 |
| Blood draw (venipuncture) | 669 | $8 | $20 |
| Comprehensive metabolic blood panel | 642 | $10 | $64 |
| Complete blood count (CBC) with differential | 588 | $8 | $36 |
| Office visit, established patient (30-39 min) | 549 | $93 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 480 | $0 | $24 |
| Magnesium level test | 442 | $7 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 310 | $1 | $114 |
| Injection of additional new drug or substance into vein | 289 | $11 | $108 |
| Administration of chemotherapy into vein, 1 hour or less | 184 | $96 | $707 |
| Ferritin level test (iron stores) | 180 | $13 | $60 |
| Iron level test | 179 | $6 | $27 |
| Iron binding capacity test | 179 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 146 | $45 | $313 |
| Injection, carboplatin, 50 mg | 126 | $2 | $300 |
| Drug injection, under skin or into muscle | 103 | $10 | $96 |
| Reticulated (young) platelet measurement | 90 | $35 | $143 |
| Microscopic examination for white blood cells with manual cell count | 84 | $4 | $22 |
| Complete blood count (CBC), automated | 84 | $6 | $34 |
| Office visit, established patient, complex (40-54 min) | 79 | $131 | $496 |
| Injection, diphenhydramine hcl, up to 50 mg | 71 | $1 | $7 |
| Unclassified drugs | 66 | $1 | $8 |
| Administration of chemotherapy into vein, each additional hour | 65 | $21 | $161 |
| Hospital follow-up visit, high complexity | 65 | $91 | $357 |
| Administration of additional new drug or substance into vein, 1 hour or less | 61 | $48 | $344 |
| Injection, zoledronic acid, 1 mg | 61 | $7 | $431 |
| Lactate dehydrogenase (enzyme) level | 60 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 57 | $21 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 51 | $15 | $100 |
| Infusion, normal saline solution , 1000 cc | 50 | $2 | $19 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 48 | $54 | $211 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 48 | $90 | $657 |
| CT scan of abdomen and pelvis with contrast | 42 | $164 | $1,067 |
| Ct scan of chest with contrast | 41 | $46 | $821 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 39 | $1,124 | $4,802 |
| Initial hospital admission, high complexity | 38 | $133 | $694 |
| Infusion into a vein for hydration, each additional hour | 32 | $10 | $75 |
| Red blood count automated, with additional calculations | 31 | $5 | $26 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 31 | $15 | $94 |
| Drawing of blood for a medical problem | 26 | $64 | $264 |
| New patient office visit (45-59 min) | 24 | $104 | $565 |
| Hospital follow-up visit, moderate complexity | 24 | $61 | $247 |
| CT scan of chest, without contrast | 20 | $36 | $686 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 19 | $178 | $700 |
| Nuclear medicine study whole body with ct scan | 16 | $1,112 | $4,929 |
| New patient office visit, complex (60-74 min) | 16 | $168 | $709 |
| Ct scan of abdomen and pelvis without contrast | 15 | $66 | $560 |
| Office visit, established patient (20-29 min) | 15 | $69 | $250 |
| Injection of drug or substance into vein | 14 | $26 | $247 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.8% high complexity
86.7% medium
8.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,089
Total received (2018-2024)
Avg $2,727/year across 7 years
Top 5% in TX for internal medicine
45
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,994 (57.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,887 (30.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,208 (11.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,419
2023$2,529
2022$9,866
2021$923
2020$233
2019$1,004
2018$115
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Kite Pharma, Inc.
$5,362
Pharmacosmos Therapeutics Inc.
$3,286
Epizyme, Inc.
$1,690
Rigel Pharmaceuticals, Inc.
$1,536
AstraZeneca Pharmaceuticals LP
$1,265
Seagen Inc.
$590
E.R. Squibb & Sons, L.L.C.
$484
Novartis Pharmaceuticals Corporation
$449
Incyte Corporation
$424
Merck Sharp & Dohme Corporation
$416
Janssen Scientific Affairs, LLC
$320
Lilly USA, LLC
$300
GlaxoSmithKline, LLC.
$241
Astellas Pharma US Inc
$239
Daiichi Sankyo Inc.
$225
Karyopharm Therapeutics Inc.
$186
EMD Serono, Inc.
$152
Sirtex Medical Inc
$152
JAZZ PHARMACEUTICALS INC.
$149
Amgen Inc.
$148
Eisai Inc.
$140
ABBVIE INC.
$128
Blueprint Medicines Corporation
$125
Merck Sharp & Dohme LLC
$115
Myovant Sciences Inc.
$111
Helsinn Therapeutics (U.S.), Inc.
$96
Seattle Genetics, Inc.
$95
Genentech USA, Inc.
$93
Regeneron Healthcare Solutions, Inc.
$87
GENZYME CORPORATION
$63
Pharmacyclics LLC, An AbbVie Company
$60
Gilead Sciences, Inc.
$56
CTI BioPharma Corp.
$45
PFIZER INC.
$41
EISAI INC.
$39
Foundation Medicine, Inc.
$28
Tempus AI, Inc
$28
GE HealthCare
$21
Iovance Biotherapeutics, Inc.
$20
Epizyme, Inc.,
$20
Aveo Pharmaceuticals, Inc.
$16
Janssen Biotech, Inc.
$16
BTG International, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Veran Medical Technologies, Inc.
$3
Top 3 companies account for 54.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Amtagvi · BLENREP · Bavencio · CABLIVI · CALQUENCE · DARZALEX · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · FOTIVDA · Fabhalta · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Nplate · ONUREG · OPDIVO · ORGOVYX · PADCEV · PIQRAY · Pomalyst · REBLOZYL · SCEMBLIX · SIR-Spheres Microspheres · Spin · TABRECTA · TAZVERIK · TRUSELTIQ · TUKYSA · Tavalisse · Tazverik · VENCLEXTA · VERZENIO · VORAXAZE · Vonjo · XOSPATA · XPOVIO · Yescarta · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for internal medicine in TX.
Equivalent to $38 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
2,000
Per 100K population
179.1
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khade is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 5%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khade experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Khade performed 17,100 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khade receive payments from pharmaceutical companies?
Yes. Dr. Khade received a total of $19,089 from 45 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khade's costs compare to other internal medicines in Plano?
Dr. Khade's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khade) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Plano
Browse internal medicines in Plano ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in TX
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in TX
Which TX internal medicines receive the most from drug and device companies.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc..
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc..
By company
Epizyme, Inc. Payments to Doctors
See all physicians who received payments from Epizyme, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology